Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CNST

Constellation Pharmaceuticals (CNST) Stock Price, News & Analysis

Constellation Pharmaceuticals logo

About Constellation Pharmaceuticals Stock (NASDAQ:CNST)

Key Stats

Today's Range
$33.99
$33.99
50-Day Range
$33.63
$33.99
52-Week Range
$17.00
$39.30
Volume
N/A
Average Volume
940,325 shs
Market Capitalization
$1.63 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CNST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Constellation Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CNST Stock News Headlines

Plc Gsk's Net Worth
Robinhood warning
A strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fastest pace in history. CNBC calls it "the largest wealth creation spree in history." Yet 1 in 3 Americans now fear their financial situation is deteriorating. There's only one way to survive, says the man who predicted 2008 and 2020, but sadly it's already too late for many.tc pixel
VHCP Management II, LLC's Net Worth
Constellation Software
See More Headlines

CNST Stock Analysis - Frequently Asked Questions

Constellation Pharmaceuticals, Inc. (NASDAQ:CNST) posted its quarterly earnings data on Sunday, May, 9th. The company reported ($0.84) earnings per share for the quarter, missing the consensus estimate of ($0.79) by $0.05.

Constellation Pharmaceuticals (CNST) raised $80 million in an initial public offering on Thursday, July 19th 2018. The company issued 5,300,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan, Jefferies and BMO Capital Markets acted as the underwriters for the IPO and Oppenheimer was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Constellation Pharmaceuticals investors own include Inovio Pharmaceuticals (INO), Kinross Gold (KGC), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Axsome Therapeutics (AXSM), Gilead Sciences (GILD) and OPKO Health (OPK).

Company Calendar

Last Earnings
5/09/2021
Today
10/19/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CNST
CIK
29806
Fax
N/A
Employees
154
Year Founded
2008

Profitability

EPS (Trailing Twelve Months)
($2.81)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$126.36 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-33.12%
Return on Assets
-29.92%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
15.39
Quick Ratio
15.39

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$8.63 per share
Price / Book
3.94

Miscellaneous

Outstanding Shares
47,915,000
Free Float
N/A
Market Cap
$1.63 billion
Optionable
Not Optionable
Beta
2.59

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:CNST) was last updated on 10/19/2025 by MarketBeat.com Staff
From Our Partners